Need help with your APIs? I offer API discovery, governance & evangelism services. Explore services →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC
Exscientia website screenshot

Exscientia

Exscientia was an Oxford UK-based AI-driven precision medicine and drug design company, founded in 2012 as a spin-out from the University of Dundee. Its platform combined generative chemistry (Centaur Chemist) with patient tissue-based screening (EVE, an automated single-cell platform for testing drug candidates directly against patient-derived tumor samples) to design small-molecule drug candidates faster and at lower cost than conventional pharma R&D. Notable firsts included EXS-21546 (an A2A antagonist developed with Evotec), DSP-1181 (the first AI-designed molecule to enter human clinical trials, with Sumitomo Dainippon Pharma), and DSP-0038 (a dual 5-HT1A/5-HT2A modulator for Alzheimer's psychosis). Exscientia maintained active pharma partnerships with Sanofi, Bristol Myers Squibb, Bayer, Sumitomo, and Merck KGaA. Exscientia was acquired by Recursion Pharmaceuticals (NASDAQ: RXRX) in an all-stock deal that closed in November 2024; the combined company operates under the Recursion brand and the legacy exscientia.ai website now redirects to recursion.com. The Exscientia name persists primarily through its GitHub organization, which continues to host open-source scientific Python packages for molecular predictive modelling (molflux), physics-based ML potentials (physicsml), antibody structure prediction (abodybuilder3), and biomolecular simulation (biosimspace) used by the wider computational chemistry and structural biology community. Exscientia did not expose any public commercial APIs, SDKs, or developer products before or after the merger; platform access was always delivered through collaborative drug-discovery agreements.

human only

Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.

Kin Score

API Evangelist profiles Exscientia the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.

Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Exscientia scores 7.4/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.

Kin Score

This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.4/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.7 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3

How we profile Exscientia

Each block below is one kind of artifact we hold for Exscientia. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Exscientia Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Every other property we hold for Exscientia — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

← All providers · Data indexed from github.com/api-evangelist/exscientia · machine-readable index on apis.io